Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen and welcome to Adaptimmune’s Q2 Financial and Business Update Conference Call. I would now like to turn the meeting call over to Ms. Juli Miller.